Cargando…

Plasma oxalate and eGFR are correlated in primary hyperoxaluria patients with maintained kidney function—data from three placebo-controlled studies

BACKGROUND: In patients with primary hyperoxaluria (PH), endogenous oxalate overproduction increases urinary oxalate excretion, leading to compromised kidney function and often kidney failure. Highly elevated plasma oxalate (Pox) is associated with systemic oxalate deposition in patients with PH and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Milliner, Dawn S., Cochat, Pierre, Hulton, Sally-Anne, Harambat, Jerome, Banos, Ana, Dehmel, Bastian, Lindner, Elisabeth
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8172484/ https://www.ncbi.nlm.nih.gov/pubmed/33515281 http://dx.doi.org/10.1007/s00467-020-04894-9

Ejemplares similares

Primary Hyperoxaluria
por: Harambat, Jérôme, et al.
Publicado: (2011)

Plasma Oxalate as a Predictor of Kidney Function Decline in a Primary Hyperoxaluria Cohort
por: Shah, Ronak Jagdeep, et al.
Publicado: (2020)

Long-Term Transplantation Outcomes in Patients With Primary Hyperoxaluria Type 1 Included in the European Hyperoxaluria Consortium (OxalEurope) Registry
por: Metry, Elisabeth L., et al.
Publicado: (2021)

Urinary monocyte chemoattractant protein 1 associated with calcium oxalate crystallization in patients with primary hyperoxaluria
por: Wang, Xiangling, et al.
Publicado: (2020)

Determinants of Kidney Failure in Primary Hyperoxaluria Type 1: Findings of the European Hyperoxaluria Consortium
por: Metry, Elisabeth L., et al.
Publicado: (2023)

Natural History of Clinical, Laboratory, and Echocardiographic Parameters of a Primary Hyperoxaluria Cohort on Long Term Hemodialysis
por: Sas, David J., et al.
Publicado: (2021)

ePHex: a phase 3, double-blind, placebo-controlled, randomized study to evaluate long-term efficacy and safety of Oxalobacter formigenes in patients with primary hyperoxaluria
por: Ariceta, Gema, et al.
Publicado: (2022)

In vivo oxalate degradation by liposome encapsulated oxalate oxidase in rat model of hyperoxaluria
por: Dahiya, Tulika, et al.
Publicado: (2013)

Plasma oxalate and glycolate concentrations in dialysis patients with and without primary hyperoxaluria type 1
por: Metry, Elisabeth L, et al.
Publicado: (2023)

Improved Outcome of Infantile Oxalosis Over Time in Europe: Data From the OxalEurope Registry
por: Deesker, Lisa J., et al.
Publicado: (2022)

Clinical and molecular characterization of primary hyperoxaluria in Egypt
por: Soliman, Neveen A., et al.
Publicado: (2022)

Nephrocalcinosis is a risk factor for kidney failure in primary hyperoxaluria
por: Tang, Xiaojing, et al.
Publicado: (2014)

Successful Treatment of Primary Hyperoxaluria Type 2 with a Combined Liver and Kidney Transplant
por: Genena, Kareem M., et al.
Publicado: (2023)

Bilateral nephrocalcinosis in primary hyperoxaluria type 1
por: Mansoor, C. A., et al.
Publicado: (2016)

A randomised Phase II/III study to evaluate the efficacy and safety of orally administered Oxalobacter formigenes to treat primary hyperoxaluria
por: Milliner, Dawn, et al.
Publicado: (2017)

Growth after renal transplantation
por: Harambat, Jérôme, et al.
Publicado: (2009)

Improved estimation of glomerular filtration rate (GFR) by comparison of eGFR(cystatin C) and eGFR(creatinine)
por: Grubb, Anders, et al.
Publicado: (2012)

Recurrence of crystalline nephropathy after kidney transplantation in APRT deficiency and primary hyperoxaluria
por: Bollée, Guillaume, et al.
Publicado: (2015)

Specific Inhibition of Hepatic Lactate Dehydrogenase Reduces Oxalate Production in Mouse Models of Primary Hyperoxaluria
por: Lai, Chengjung, et al.
Publicado: (2018)

Hydroxycitric Acid Tripotassium Inhibits Calcium Oxalate Crystal Formation in the Drosophila Melanogaster Model of Hyperoxaluria
por: Han, Shanfu, et al.
Publicado: (2019)

An engineered bacterial therapeutic lowers urinary oxalate in preclinical models and in silico simulations of enteric hyperoxaluria
por: Lubkowicz, David, et al.
Publicado: (2022)

Chronic liver disease and hepatic calcium-oxalate deposition in patients with primary hyperoxaluria type I
por: Recker, Pia, et al.
Publicado: (2022)

Transplantation for Primary Hyperoxaluria Type 1: Designing New Strategies in the Era of Promising Therapeutic Perspectives
por: Devresse, Arnaud, et al.
Publicado: (2020)

RIFLE and AKIN - maintain the momentum and the GFR!
por: Pickering, John W, et al.
Publicado: (2009)

Assessment of GFR by four methods in adults in Ashanti, Ghana: the need for an eGFR equation for lean African populations
por: Eastwood, John B., et al.
Publicado: (2010)

Dominant negative mutation in oxalate transporter SLC26A6 associated with enteric hyperoxaluria and nephrolithiasis
por: Cornière, Nicolas, et al.
Publicado: (2022)

Cystacin C-based eGFR and Creatinine Clearance-based eGFR in Patients with Severe Motor and Intellectual Disabilities
por: Tamura, Kouichi, et al.
Publicado: (2023)

Plasma oxalate: comparison of methodologies
por: Stokes, Felicity, et al.
Publicado: (2020)

Hyperoxaluria leads to dysbiosis and drives selective enrichment of oxalate metabolizing bacterial species in recurrent kidney stone endures
por: Suryavanshi, Mangesh V., et al.
Publicado: (2016)

Reversal of Gastric Bypass Resolves Hyperoxaluria and Improves Oxalate Nephropathy Secondary to Roux-en-Y Gastric Bypass
por: Agrawal, Varun, et al.
Publicado: (2016)

Transcriptional study of hyperoxaluria and calcium oxalate nephrolithiasis in male rats: Inflammatory changes are mainly associated with crystal deposition
por: Joshi, Sunil, et al.
Publicado: (2017)

Specific populations of urinary extracellular vesicles and proteins differentiate type 1 primary hyperoxaluria patients without and with nephrocalcinosis or kidney stones
por: Jayachandran, Muthuvel, et al.
Publicado: (2020)

Correction to: Specific populations of urinary extracellular vesicles and proteins differentiate type 1 primary hyperoxaluria patients without and with nephrocalcinosis or kidney stones
por: Jayachandran, Muthuvel, et al.
Publicado: (2021)

Autophagy inhibition attenuates hyperoxaluria-induced renal tubular oxidative injury and calcium oxalate crystal depositions in the rat kidney
por: Duan, Xiaolu, et al.
Publicado: (2018)

Point of Care eGFR and the Prediction of Outcomes in Pneumonia
por: Suk, Chi-won, et al.
Publicado: (2019)

Impact of a single eGFR and eGFR-estimating equation on chronic kidney disease reclassification: a cohort study in primary care
por: Hirst, Jennifer A, et al.
Publicado: (2018)

Potential relationship between eGFR(cystatin C)/eGFR(creatinine)‐ratio and glomerular basement membrane thickness in diabetic kidney disease
por: Öberg, Carl M., et al.
Publicado: (2021)

International Collaboration for the Epidemiology of eGFR in Low and Middle Income Populations - Rationale and core protocol for the Disadvantaged Populations eGFR Epidemiology Study (DEGREE)
por: Caplin, Ben, et al.
Publicado: (2017)

Evaluation of a high‐performance liquid chromatography method for urinary oxalate determination and investigation regarding the pediatric reference interval of spot urinary oxalate to creatinine ratio for screening of primary hyperoxaluria
por: Shen, Ying, et al.
Publicado: (2021)

Short‐Term Change in eGFR and Risk of Cardiovascular Events
por: Turin, Tanvir Chowdhury, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_tbipgqe8ec7usffdktrp8u6t4q